These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 12523486
1. In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors. Wesołowska A. Pol J Pharmacol; 2002; 54(4):327-41. PubMed ID: 12523486 [Abstract] [Full Text] [Related]
2. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders. Heal DJ, Smith SL, Fisas A, Codony X, Buschmann H. Pharmacol Ther; 2008 Feb; 117(2):207-31. PubMed ID: 18068807 [Abstract] [Full Text] [Related]
3. Novel 2-aminotetralin and 3-aminochroman derivatives as selective serotonin 5-HT7 receptor agonists and antagonists. Holmberg P, Sohn D, Leideborg R, Caldirola P, Zlatoidsky P, Hanson S, Mohell N, Rosqvist S, Nordvall G, Johansson AM, Johansson R. J Med Chem; 2004 Jul 29; 47(16):3927-30. PubMed ID: 15267230 [Abstract] [Full Text] [Related]
4. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor. Brüss M, Kiel S, Bönisch H, Kostanian A, Göthert M. Neurochem Int; 2005 Aug 29; 47(3):196-203. PubMed ID: 15896881 [Abstract] [Full Text] [Related]
9. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity. Medina RA, Sallander J, Benhamú B, Porras E, Campillo M, Pardo L, López-Rodríguez ML. J Med Chem; 2009 Apr 23; 52(8):2384-92. PubMed ID: 19326916 [Abstract] [Full Text] [Related]
10. Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s. Dupuis DS, Mannoury la Cour C, Chaput C, Verrièle L, Lavielle G, Millan MJ. Eur J Pharmacol; 2008 Jul 07; 588(2-3):170-7. PubMed ID: 18511034 [Abstract] [Full Text] [Related]
11. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling. Hirst WD, Abrahamsen B, Blaney FE, Calver AR, Aloj L, Price GW, Medhurst AD. Mol Pharmacol; 2003 Dec 07; 64(6):1295-308. PubMed ID: 14645659 [Abstract] [Full Text] [Related]
12. 8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligands. Heightman TD, Gaster LM, Pardoe SL, Pilleux JP, Hadley MS, Middlemiss DN, Price GW, Roberts C, Scott CM, Watson JM, Gordon LJ, Holland VA, Powles J, Riley GJ, Stean TO, Trail BK, Upton N, Austin NE, Ayrton AD, Coleman T, Cutler L. Bioorg Med Chem Lett; 2005 Oct 01; 15(19):4370-4. PubMed ID: 16039851 [Abstract] [Full Text] [Related]
15. 4-(2-Aminoethoxy)-N-(phenylsulfonyl)indoles as novel 5-HT6 receptor ligands. Zhou P, Yan Y, Bernotas R, Harrison BL, Huryn D, Robichaud AJ, Zhang GM, Smith DL, Schechter LE. Bioorg Med Chem Lett; 2005 Mar 01; 15(5):1393-6. PubMed ID: 15713394 [Abstract] [Full Text] [Related]
20. 5-HT6 receptor antagonists: prospects for the treatment of cognitive disorders including dementia. Johnson CN, Ahmed M, Miller ND. Curr Opin Drug Discov Devel; 2008 Sep 19; 11(5):642-54. PubMed ID: 18729016 [Abstract] [Full Text] [Related] Page: [Next] [New Search]